Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

627291

registered interest
date	02/11/2016
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Armed Forces: Redundancy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, how many (a) Army, (b) Royal Air Force and (c) Royal Navy officers who had served for more than 12 but fewer than 16 years were made compulsorily redundant during the four tranches of redundancies from September 2011 to June 2014.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	51540
answer	answer is ministerial correction date of answer 08/11/2016 answer text <p>The requested information is provided below:</p><p> </p><p> </p><p><strong>Involuntary Redundancies September 2011 – June 2014, UK Regular Armed Forces Officers with 13-15 years of service</strong></p><table><tbody><tr><td><p>Royal Navy</p></td><td><p>10</p></td></tr><tr><td><p>Army</p></td><td><p>30</p></td></tr><tr><td><p>Royal Air Force</p></td><td><p>30</p></td></tr></tbody></table><p> </p><p>Notes: Figures for UK Regular Service Officers include Nursing Services, but exclude Full Time Reserve Service personnel, Gurkhas, mobilised Reservists, Military Provost Guard Service, Locally Engaged Personnel, Non Regular Permanent Staff, High Readiness Reserve and Expeditionary Forces Institute personnel. All figures are rounded to the nearest 10.</p> answering member constituency Milton Keynes North answering member printed Mark Lancaster question first answered 08/11/2016 16:06:23 answering member 1544 label Biography information for Lord Lancaster of Kimbolton
tabling member	4433 label Biography information for Thangam Debbonaire

626585

registered interest
date	01/11/2016
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Universities: Competition
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Education, what steps she is taking to ensure that UK universities remain globally competitive after the UK leaves the EU.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	51362
answer	answer is ministerial correction date of answer 04/11/2016 answer text <p>UK universities are home to both world-class teaching and life-changing research, and exiting the EU will not change this. The Government has already announced that EU students applying for a place at an English university or further education institution in 2017/2018 (or before) will continue to be eligible for student loans and grants for the duration of their course, even if the UK exits the EU during that period. To support research and innovation, we have also announced that HM Treasury will underwrite funding for approved Horizon 2020 projects applied for before the UK leaves the EU, including where specific projects continue beyond the UK’s departure.</p><p>Future arrangements for EU students and staff, funding and also UK students studying abroad will need to be considered as part of wider discussions about the UK’s relationship with the EU. The Government is fully committed to ensuring that we get the best possible outcome for the higher education sector from its negotiations with the EU.</p> answering member constituency Orpington answering member printed Joseph Johnson question first answered 04/11/2016 13:18:03 answering member 4039 label Biography information for Lord Johnson of Marylebone
tabling member	4433 label Biography information for Thangam Debbonaire

626637

registered interest
date	01/11/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Nivolumab
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 27 June 2014 to Question 40281, on what date he expects NICE to publish the results of the consultation on the guidance on the use of nivolumab for the treatment of lung cancer.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	51363
answer	answer is ministerial correction date of answer 04/11/2016 answer text <p>The National Institute for Health and Care Excellence (NICE) is currently carrying out two separate technology appraisals of nivolumab (Opdivo) for previously treated locally advanced or metastatic non-squamous non-small cell lung cancer and previously treated locally advanced or metastatic squamous non-small-cell lung cancer after prior chemotherapy in adults.</p><p> </p><p>NICE is currently consulting on draft guidance for both appraisals and the closing date for comments is 4 November 2016. Subsequent timescales for guidance development are yet to be confirmed by NICE. NICE will publish comments received in response to the consultation and its responses alongside the next iteration of its draft guidance.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 04/11/2016 10:38:53 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4433 label Biography information for Thangam Debbonaire

626753

registered interest
date	01/11/2016
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Intellectual Property: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what his Department's policy is on using the flexibility provided by the Trade Related Aspects of Intellectual Property Rights under World Trade Organisation rules for compulsory license for the Kadcyla form of trastuzumab emtansine for UK patients.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	51439
answer	answer is ministerial correction date of answer 04/11/2016 answer text <p>The UK Patents Act 1977, in line with the WTO TRIPS Agreement, provides for compulsory licenses in certain circumstances.</p><p> </p><p>Kadcyla (trastuzumab emtansine) is currently available to patients in England for the treatment of HER2-positive locally advanced, unresectable or metastatic breast cancer through the Cancer Drugs Fund.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) is currently reviewing its technology appraisal guidance on trastuzumab emtansine for refractory, HER2 positive breast cancer. NICE expects to publish its updated guidance in February 2017.</p><p> </p> answering member constituency Orpington answering member printed Joseph Johnson question first answered 04/11/2016 14:03:54 answering member 4039 label Biography information for Lord Johnson of Marylebone
tabling member	4433 label Biography information for Thangam Debbonaire